Clinical Characteristics, Diagnosis, Treatment, and Mortality Rate of TB/COVID-19 Coinfectetd Patients: A Systematic Review
Introduction: Novel coronavirus (COVID-19) and tuberculosis (TB) are the newest and one of the oldest global threats, respectively. In the COVID-19 era, due to the health system's focus on the COVID-19 epidemic, the national TB control program received less attention, leading to a worsening of...
Guardado en:
Autores principales: | Maryam Koupaei, Adel Naimi, Narges Moafi, Paria Mohammadi, Faezeh Sadat Tabatabaei, Soroosh Ghazizadeh, Mohsen Heidary, Saeed Khoshnood |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6af2e5cb05474a5e9b96121d3858e2eb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Control of The Spread of TB-HIV/AIDS Coinfection Using Optimal Control
por: Yuyun Monita, et al.
Publicado: (2021) -
HIV Is Associated with Modified Humoral Immune Responses in the Setting of HIV/TB Coinfection
por: Esther van Woudenbergh, et al.
Publicado: (2020) -
Mobile Health Intervention for Outpatient Treatment of Tuberculosis and HIV Infection
por: S. N. Zhdanova, et al.
Publicado: (2020) -
Genitourinary Tuberculosis: A Comprehensive Review of a Neglected Manifestation in Low-Endemic Countries
por: Guglielmo Mantica, et al.
Publicado: (2021) -
The Role of QuantiFERON-TB Gold Plus in Mycobacterium Tuberculosis Detection in a Severe HIV Immunocompromised Patient—Case Report
por: Florentina Dumitrescu, et al.
Publicado: (2021)